Anti-GLRA1/ HKPX1/ STHE monoclonal antibody
Anti-GLRA1/ HKPX1/ STHE antibody for FACS & in-vivo assay
Go to GLRA1/GLRA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T50269-Ab-1/ GM-Tg-hg-T50269-Ab-2 | Anti-Human GLRA1 monoclonal antibody | Human |
GM-Tg-rg-T50269-Ab-1/ GM-Tg-rg-T50269-Ab-2 | Anti-Rat GLRA1 monoclonal antibody | Rat |
GM-Tg-mg-T50269-Ab-1/ GM-Tg-mg-T50269-Ab-2 | Anti-Mouse GLRA1 monoclonal antibody | Mouse |
GM-Tg-cynog-T50269-Ab-1/ GM-Tg-cynog-T50269-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GLRA1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T50269-Ab-1/ GM-Tg-felg-T50269-Ab-2 | Anti-Feline GLRA1 monoclonal antibody | Feline |
GM-Tg-cang-T50269-Ab-1/ GM-Tg-cang-T50269-Ab-2 | Anti-Canine GLRA1 monoclonal antibody | Canine |
GM-Tg-bovg-T50269-Ab-1/ GM-Tg-bovg-T50269-Ab-2 | Anti-Bovine GLRA1 monoclonal antibody | Bovine |
GM-Tg-equg-T50269-Ab-1/ GM-Tg-equg-T50269-Ab-2 | Anti-Equine GLRA1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T50269-Ab-1/ GM-Tg-hg-T50269-Ab-2; GM-Tg-rg-T50269-Ab-1/ GM-Tg-rg-T50269-Ab-2; GM-Tg-mg-T50269-Ab-1/ GM-Tg-mg-T50269-Ab-2; GM-Tg-cynog-T50269-Ab-1/ GM-Tg-cynog-T50269-Ab-2; GM-Tg-felg-T50269-Ab-1/ GM-Tg-felg-T50269-Ab-2; GM-Tg-cang-T50269-Ab-1/ GM-Tg-cang-T50269-Ab-2; GM-Tg-bovg-T50269-Ab-1/ GM-Tg-bovg-T50269-Ab-2; GM-Tg-equg-T50269-Ab-1/ GM-Tg-equg-T50269-Ab-2 |
Products Name | Anti-GLRA1 monoclonal antibody |
Format | mab |
Target Name | GLRA1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GLRA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species GLRA1/ HKPX1/ STHE VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLP001517 | human GLRA1 Lentivirus plasmid |
ORF Viral Vector | vGMLP001517 | human GLRA1 Lentivirus particle |
ORF Viral Vector | pGMLPm001398 | mouse Glra1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001398 | mouse Glra1 Lentivirus particle |
Target information
Target ID | GM-T50269 |
Target Name | GLRA1 |
Gene ID | 2741,14654,25674,713940,489172,101099022,281783,100060055 |
Gene Symbol and Synonyms | GLRA1,GLYRA1,HKPX1,nmf11,oscillator,ot,spasmodic,spd,STHE |
Uniprot Accession | P23415,P07727,P57695 |
Uniprot Entry Name | GLRA1_HUMAN,GLRA1_RAT,GLRA1_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000145888 |
Target Classification | Ion Channel |
The target: GLRA1, gene name: GLRA1, also named as HKPX1, STHE. The protein encoded by this gene is a subunit of a pentameric inhibitory glycine receptor, which mediates postsynaptic inhibition in the central nervous system. Defects in this gene are a cause of startle disease (STHE), also known as hereditary hyperekplexia or congenital stiff-person syndrome. Multiple transcript variants encoding different isoforms have been found. [provided by RefSeq, Dec 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.